Vanguard Personalized Indexing Management, LLC Intellia Therapeutics, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$6.09 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$23.82 - $32.8 $52,332 - $72,061	2,197 Added 32.56%	8,944 $246,000
Q4 2023 Feb 07, 2024	BUY	$23.16 - $32.34 $156,260 - $218,197	6,747 New	6,747 $205,000
Q2 2023 Jul 28, 2023	SELL	$34.58 - $46.03 $33,611 - $44,741	-972 Reduced 14.24%	5,854 $238,000
Q1 2023 May 10, 2023	BUY	$33.3 - $44.82 $227,305 - $305,941	6,826 New	6,826 $254,000
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $14,774 - $19,645	274 Added 4.37%	6,546 $366,000
Q2 2022 Aug 09, 2022	BUY	$38.49 - $76.21 $93,299 - $184,733	2,424 Added 62.99%	6,272 $325,000
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $80,121 - $163,611	1,375 Added 55.6%	3,848 $280,000
Q4 2021 Feb 23, 2022	SELL	$100.76 - $138.36 $119,501 - $164,094	-1,186 Reduced 32.41%	2,473 $292,000
Q3 2021 Nov 09, 2021	BUY	$132.37 - $176.78 $484,341 - $646,838	3,659 New	3,659 $491,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$149 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$117 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.6 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.3 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account